WWiKY is managed by experts in a range of relevant scientific and clinical fields including oncology, radiotherapy, drug development, and pharmacology. In addition, executive team members also possess experience in commercialization, clinical trials, regulatory and medical affairs, and drug manufacturing.
Dr. Piyush Kumar, PhD
President, Chief Executive Officer
Dr. MiCHAEL Weinfeld, PhD
Vice President & Chief Scientific Officer
Dr. John Yao, PhD
Chief Financial Officer
Advisory Board
Dr. Leonard I. Wiebe, PhD, DSc.
Adjunct Professor, Oncology, University of Alberta, Edmonton; Experience: Tumor
Hypoxia, Radiopharmaceuticals
Dr. Michael Sawyer, DM, FRCP
Medical Oncologist, Cross Cancer Institute; Experience: Clinical Lead on the WWiKY Biosciences Inc. sponsored Phase I/II Cancer clinical trial
Dr. Naresh Jha, MD
Radiation Oncologist, Cross Cancer Institute; Experience: Radiotherapy, Head & Neck Cancers; Collaborator on the WWiKY Biosciences Inc. sponsored Phase I/II Cancer clinical trial
Dr. Sharon Barker, PhD
Experience: Investment and Financial Advisor Johnson & Johnson, Canada, Ex- CEO WWiKY Biosciences Inc., Edmonton
Collaborators
Prof. Ravin Narain
A Chemical and Biomedical Engineer that is collaborating with WWiKY BioSciences on the development of bioreductively-activated nanotheranostics’ pipeline